Intrinsic capacity as proposed by the World Health Organization and 30-month mortality among older adults in long-term care facilities / Capacidade Intrínseca proposta pela Organização Mundial de Saúde e mortalidade em residentes de Instituição de Longa Permanência para Idosos em 30 meses

Objetivo: Analisar o efeito da Capacidade Intrínseca na mortalidade de 30 meses em residentes idosos de Instituição de Longa Permanência. Metodologia: Estudo de coorte prospectivo realizado de julho de 2020 a dezembro de 2022 com análise de sobrevivência de idosos residentes de ILPIs brasileiras. Na avaliação inicial (M0) foram avaliados 209 idosos residentes quanto aos dados demográficos e clínicos (doenças diagnosticadas e medicações utilizadas); capacidade intrínseca segundo ICOPE nos domínios cognição, psicológico, audição, visão, vitalidade e locomotor; capacidade funcional pelas atividades básicas de vida diária (índice de Katz) e fragilidade (escala FRAIL). Após 30 meses, foi avaliada a ocorrência de óbito. Resultados: Em M0, a média da idade dos residentes era de 82 anos (±11,21), 65,07% eram do sexo feminino, 94,26% de cor branca e 88,04% tinham multimorbidade. Apresentaram alteração em quatro ou mais domínios da capacidade intrínseca 54,07% (n = 113) dos residentes, sendo o domínio mais alterado a locomoção (82,78%). Eram totalmente dependentes para as atividades básicas de vida diária 43,54% dos idosos, e 42,58% eram frágeis. Após 30 meses de acompanhamento, 33,49% (n = 70) dos idosos evoluíram para óbito. Na análise da sobrevida para óbito, houve associação estatisticamente significativa do evento com alteração em quatro ou mais domínios da capacidade intrínseca (p = 0,044). Conclusão: a alteração de quatro ou mais domínios da capacidade intrínseca está associada com óbito em residentes de ILPI. (AU)

Objective: To analyze the impact of intrinsic capacity on 30-month mortality among older adults living in long-term care facilities (LTCFs). Methods: Prospective cohort study with survival analysis conducted from July 2020 to December 2022 among older adults living in Brazilian LTCFs. At baseline (T0), 209 older residents were evaluated for demographic profile, clinical data (diagnosed diseases and current medications), intrinsic capacity according to ICOPE (cognitive capacity, psychological capacity, hearing capacity, visual capacity, vitality, and locomotor capacity domains), functional capacity (Katz Index of Independence in Activities of Daily Living), and frailty (FRAIL scale). At 30 months, mortality in the sample was assessed. Results: At T0, the mean age of residents was 82 (SD, 11.21) years; 65.07% were female, 94.26% were white, and 88.04% had multimorbidity. Overall, 54.07% (n = 113) of residents exhibited changes in four or more domains of intrinsic capacity, with locomotor capacity being the most commonly impaired domain (82.78%); 43.54% were completely dependent for basic activities of daily living, and 42.58% were frail. At 30-month follow-up, 33.49% (n = 70) of residents had died. Survival analysis revealed a statistically significant association between death and impairment in four or more domains of intrinsic capacity (p = 0.044). Conclusion: Impairment in four or more domains of intrinsic capacity is associated with death in LTCF residents. (AU)

Identifying and Managing Frailty: A Survey of UK Healthcare Professionals.

Frailty is a common condition that leads to multiple adverse outcomes. Frailty should be identified and managed in a holistic, evidence-based and patient-centered way. We aimed to understand how UK healthcare professionals (HCPs) identify and manage frailty in comparison with UK Fit for Frailty guidelines, their frailty training, their confidence in providing support and organizational pathways for this. An online mixed-methods survey was distributed to UK HCPs supporting older people through professional bodies, special interest groups, key contacts, and social media. From 137 responses, HCPs valued frailty assessment but used a mixture of tools that varied by profession. HCPs felt confident managing frailty and referred older people to a wide range of supportive services, but acknowledged a lack of formalized training opportunities, systems, and pathways for frailty management. Clearer pathways, more training, and stronger interprofessional communication, appropriate to each setting, may further support HCPs in frailty management.

The use of ChatGPT in scientific publishing / O uso do ChatGPT na publicação científica

The use of Generative Pretrained Transformer (ChatGPT), an artificial intelligence tool, for writing scientific articles has been reason for discussion by the academic community ever since its launch in late 2022. This artificial intelligence technology is becoming capable of generating fluent language, and distinguishing between text produced by ChatGPT and that written by people is becoming increasingly difficult. Here, we will present some topics to be discussed: (1) ensuring human verification; (2) establishing accountability rules; (3) avoiding the automatization of scientific production; (4) favoring truly open-source large language models (LLMs); (5) embracing the benefits of artificial intelligence; and (6) broadening the debate. With the emergence of these technologies, it is crucial to regulate, with continuous updates, the development and responsible use of LLMs with integrity, transparency, and honesty in research, along with scientists from various areas of knowledge, technology companies, large research funding bodies, science academies and universities, editors, non-governmental organizations, and law experts

O uso do Generative Pretrained Transformer (ChatGPT), ferramenta de inteligência artificial, na redação de artigos científicos, tem sido motivo de discussão pela comunidade acadêmica desde seu lançamento, no fim de 2022. Essa tecnologia de inteligência artificial está ganhando a capacidade de gerar linguagem fluente, sendo cada vez mais difícil distingui-la dos textos escritos por pessoas. Serão apresentados alguns aspectos para serem debatidos: (1) assegurar a verificação humana; (2) desenvolver regras de responsabilidade; (3) evitar a automatização da produção científica; (4) dar preferência a grandes modelos de linguagem verdadeiramente (LLMs) abertos; (5) abraçar os benefícios da IA; e (6) ampliar o debate. Com o surgimento dessas tecnologias, faz-se necessário regulamentar, com atualização contínua, o desenvolvimento e o uso responsável dos LLMs com integridade, transparência e honestidade na pesquisa, com participação de cientistas de diversas disciplinas, empresas de tecnologia, grandes financiadores de pesquisas, academias de ciências e universidades, editores, organizações não governamentais (ONGs) e especialistas jurídicos

Outpatient versus inpatient treatment for acute pulmonary embolism.

BACKGROUND: Pulmonary embolism (PE) is a common life-threatening cardiovascular condition, with an incidence of 23 to 69 new cases per 100,000 people each year. For selected low-risk patients with acute PE, outpatient treatment might provide several advantages over traditional inpatient treatment, such as reduction of hospitalisations, substantial cost savings, and improvements in health-related quality of life. This is an update of an earlier Cochrane Review. OBJECTIVES: To assess the effects of outpatient versus inpatient treatment in low-risk patients with acute PE. SEARCH METHODS: We used standard, extensive Cochrane search methods. The latest search date was 31 May 2021. SELECTION CRITERIA: We included randomised controlled trials (RCTs) of outpatient versus inpatient treatment of adults (aged 18 years and over) diagnosed with low-risk acute PE. DATA COLLECTION AND ANALYSIS: We used standard Cochrane methods. Our primary outcomes were short- and long-term all-cause mortality. Secondary outcomes were bleeding, adverse effects, recurrence of PE, and patient satisfaction. We used GRADE to assess certainty of evidence for each outcome. MAIN RESULTS: We did not identify any new studies for this update. We included a total of two RCTs involving 453 participants. Both trials discharged participants randomised to the outpatient group within 36 hours of initial triage, and both followed participants for 90 days. One study compared the same treatment regimens in both outpatient and inpatient groups, and the other study used different treatment regimens. There was no clear difference in treatment effect for the outcomes of mortality at 30 days (risk ratio (RR) 0.33, 95% confidence interval (CI) 0.01 to 7.98; 2 studies, 453 participants; low-certainty evidence), mortality at 90 days (RR 0.98, 95% CI 0.06 to 15.58; 2 studies, 451 participants; low-certainty evidence), major bleeding at 14 days (RR 4.91, 95% CI 0.24 to 101.57; 2 studies, 445 participants; low-certainty evidence) and at 90 days (RR 6.88, 95% CI 0.36 to 132.14; 2 studies, 445 participants; low-certainty evidence), minor bleeding (RR 1.08, 95% CI 0.07 to 16.79; 1 study, 106 participants; low-certainty evidence), recurrent PE within 90 days (RR 2.95, 95% CI 0.12 to 71.85; 2 studies, 445 participants; low-certainty evidence), and patient satisfaction (RR 0.97, 95% CI 0.90 to 1.04; 2 studies, 444 participants; moderate-certainty evidence). We downgraded the certainty of the evidence because the CIs were wide and included treatment effects in both directions, the sample sizes and numbers of events were small, and it was not possible to determine the effect of missing data or the presence of publication bias. The included studies did not assess PE-related mortality or adverse effects, such as haemodynamic instability, or adherence to treatment. AUTHORS' CONCLUSIONS: Currently, only low-certainty evidence is available from two published randomised controlled trials on outpatient versus inpatient treatment in low-risk patients with acute PE. The studies did not provide evidence of any clear difference between the interventions in overall mortality, bleeding, or recurrence of PE.

Impact of long-term care facilities' size on adherence to COVID-19' infection prevention guidance. / Impacto do tamanho das instituições de longa permanência na adesão às orientações de prevenção de infecções por COVID-19.

OBJECTIVE: to evaluate the adherence of Brazilian long-term care facilities to the World Health Organization Infection Prevention and Control guidance, and assess the association of their size with the adherence to these recommendations. METHOD: cross-sectional study conducted with facilities' managers. Authors developed a 20-item questionnaire based on this guidance, and a global score of adherence, based on the adoption of these recommendations. Adherence was classified as (1) excellent for those who attended ≥14 out of 20 recommendations; (2) good for 10 to 13 items; and (3) low for those with less than ten items. Facilities' sizes were established as small, intermediate, and large according to a two-step cluster analysis. Descriptive statistics and chi-square tests were used at a 5% significance level. RESULTS: among 362 included facilities, 308 (85.1%) adhered to 14 or more recommendations. Regarding its size, adherence to screening COVID-19 symptoms of visitors (p=0.037) and isolating patients until they have had two negative laboratory tests (p=0.032) were lower on larger ones compared to medium and small facilities. CONCLUSION: adherence to COVID-19 mitigation measures in Brazilian facilities was considered excellent for most of the recommendations, regardless of the size of the units.

Impacto do tamanho das instituições de longa permanência na adesão às orientações de prevenção de infecções por COVID-19 / Impact of long-term care facilities' size on adherence to COVID-19' infection prevention guidance / Impacto del tamaño de las instituciones de larga estancia en la adhesión a las orientaciones de prevención de infecciones por COVID-19

Resumo Objetivo: avaliar a adesão das instituições de longa permanência brasileiras às orientações de Prevenção e Controle de Infecções da Organização Mundial da Saúde, observando a associação entre seu porte e a adesão a essas recomendações. Método: estudo transversal realizado com gestores de estabelecimentos. Os autores desenvolveram um questionário de 20 itens, com base nessas orientações, e um escore global de adesão, com base na adesão a essas recomendações. A adesão foi classificada como (1) excelente para aquelas que atenderam ≥14 de 20 recomendações, (2) bom para 10 a 13 itens e (3) baixo para aquelas com menos de dez itens. O tamanho das instalações foi classificado como pequeno, médio e grande, de acordo com uma análise de cluster em duas etapas. Estatística descritiva e teste de qui-quadrado foram utilizados com nível de significância de 5%. Resultados: das 362 instituições incluídas, 308 (85,1%) aderiram a 14 ou mais recomendações. Em relação ao seu tamanho, a adesão à triagem de sintomas de COVID-19 dos visitantes (p=0,037) e ao isolamento de pacientes até que tenham dois exames laboratoriais negativos (p=0,032) foi menor em estabelecimentos maiores, em comparação com estabelecimentos de médio e pequeno porte. Conclusão: a adesão às medidas de mitigação da COVID-19 nas unidades brasileiras foi considerada excelente para a maioria das recomendações, independentemente do porte das unidades.

Abstract Objective: to evaluate the adherence of Brazilian long-term care facilities to the World Health Organization Infection Prevention and Control guidance, and assess the association of their size with the adherence to these recommendations. Method: cross-sectional study conducted with facilities' managers. Authors developed a 20-item questionnaire based on this guidance, and a global score of adherence, based on the adoption of these recommendations. Adherence was classified as (1) excellent for those who attended ≥14 out of 20 recommendations; (2) good for 10 to 13 items; and (3) low for those with less than ten items. Facilities' sizes were established as small, intermediate, and large according to a two-step cluster analysis. Descriptive statistics and chi-square tests were used at a 5% significance level. Results: among 362 included facilities, 308 (85.1%) adhered to 14 or more recommendations. Regarding its size, adherence to screening COVID-19 symptoms of visitors (p=0.037) and isolating patients until they have had two negative laboratory tests (p=0.032) were lower on larger ones compared to medium and small facilities. Conclusion: adherence to COVID-19 mitigation measures in Brazilian facilities was considered excellent for most of the recommendations, regardless of the size of the units.

Resumen Objetivo: evaluar la adhesión de instituciones brasileñas de larga estancia a las orientaciones de Prevención y Control de Infecciones de la Organización Mundial de la Salud y evaluar la asociación entre su tamaño y la adhesión a esas recomendaciones. Método: estudio transversal realizado con gerentes de establecimientos. Los autores desarrollaron un cuestionario de 20 ítems basado en estas directrices y un puntaje general de cumplimiento acorde a la observancia de estas recomendaciones. La adhesión se calificó (1) excelente para aquellas que cumplieron con ≥14 de 20 recomendaciones; (2) buena para 10 a 13 artículos; y (3) baja para aquellas con menos de diez elementos. El tamaño de las instalaciones se clasificó como pequeños, medianos y grandes de acuerdo con un análisis de clúster de dos pasos. Se utilizó estadística descriptiva y la prueba de chi-cuadrado con un nivel de significancia del 5%. Resultados: de las 362 instituciones incluidas, 308 (85,1%) se adhirieron a 14 o más recomendaciones. En cuanto a su tamaño, la adhesión al cribado de síntomas de COVID-19 de los visitantes (p=0,037) y al aislamiento de los pacientes hasta que tengan dos pruebas de laboratorio negativas (p=0,032) fue menor en los establecimientos más grandes en comparación con los establecimientos medianos y pequeños. Conclusión: la adhesión a las medidas de mitigación de la COVID-19 en las unidades brasileñas fue considerada excelente para la mayoría de las recomendaciones, independientemente del tamaño de las unidades.

Knowledge and attitudes in dementia held by general practitioners in the primary care setting of Botucatu, São Paulo, Brazil.

BACKGROUND: Alzheimer's disease (AD) is the leading cause of dementia worldwide. Despite alarming evidence on dementia prevalence, the condition is still underdiagnosed by general practitioners (GPs) in primary care. Early detection of the disease is beneficial for patients and relatives, who should be provided comprehensive guidance on dealing with dementia complications, covering medical, family and social aspects, thereby providing an opportunity to plan for the future. OBJECTIVE: The objective of this study was to assess the knowledge of and attitudes toward dementia held by GPs from a city in the interior of São Paulo State, Brazil. METHODS: A non-randomized intervention study was conducted involving six lectures about dementia. Before and after the intervention, the participating physicians completed two quizzes about knowledge of and attitudes towards dementia. The study was carried out in the primary care services of the town and a total of 34 GPs participated in the study. RESULTS: The mean age of the sample was 33.9 (±10.2) years and the majority (76.5%) of the sample had not undertaken medical residency training. The mean number of correct answers on the Knowledge Quiz about dementia before and after the training intervention was 59.6 and 71.2% (p<0.001), respectively. The comparison of the mean responses on the Attitude Quiz revealed no statistically significant difference between the two applications of the instrument, before and after intervention (p=0.059). CONCLUSIONS: More training for GPs on dementia should be provided.

COVID-19 in long-term care facilities in Brazil: serological survey in a post-outbreak setting.

This cross-sectional seroepidemiological survey presents the seroprevalence of SARS-CoV-2 in a population living in 15 Long-Term Care Facilities (LTCFs), after two intra-institutional outbreaks of COVID-19 in the city of Botucatu, Sao Paulo State, Brazil. Residents were invited to participate in the serological survey performed in June and July 2020. Sociodemographic and clinical characterization of the participants as well as the LTCF profile were recorded. Blood samples were collected, processed and serum samples were tested using the rapid One Step COVID-19 immunochromatography test to detect IgM and IgG anti-SARS-CoV-2. Among 209 residents, the median of age was 81 years old, 135 (64.6%) were female and 171 (81.8%) self-referred as being white. An overall seroprevalence of 11.5% (95% CI: 7.5% - 16.6%) was found. The highest seroprevalences of 100% and 76.9% were observed in LTCFs that had experienced COVID-19 outbreaks. Most residents with positive immunochromatography tests (70.8%) referred previous contact with a confirmed COVID-19 case. Although there was a relatively low seroprevalence of COVID-19 in the total number of elderly people, this population is highly vulnerable and LTCFs are environments at higher risk for COVID-19 dissemination. A well-established test for COVID-19 policies, the adequate characterization of the level of interaction between residents and the healthcare provider team and the level of complexity of care are crucial to monitor and control the transmission of SARS-CoV-2 in these institutions.

Mapping Research Conducted on Long-Term Care Facilities for Older People in Brazil: A Scoping Review.

This scoping review aimed to explore the characteristics, strengths, and gaps in research conducted in Brazilian long-term care facilities (LTCFs) for older adults. Electronic searches investigating the residents (≥60 years old), their families, and the LTCF workforce in Brazil were conducted in Medline, EMBASE, LILACS, and Google Scholar, within the timescale of 1999 to 2018, limited to English, Portuguese, or Spanish. The reference lists were hand searched for additional papers. The Mixed Methods Appraisal Tool (MMAT) was used for critical appraisal of evidence. Data were reported descriptively considering the study design, using content analysis: 327 studies were included (n = 159 quantitative non-randomized, n = 82 quantitative descriptive, n = 67 qualitative, n = 11 mixed methods, n = 6 randomized controlled trials, and n = 2 translation of assessment tools). Regardless of the study design, most were conducted in a single LTCF (45.8%), in urban locations (84.3%), and in non-profit settings (38.7%). The randomized trials and descriptive studies presented the lowest methodological quality based on the MMAT. This is the first review to provide an overview of research on LTCFs for older people in Brazil. It illustrates an excess of small-scale, predominantly qualitative papers, many of which are reported in ways that do not allow the quality of the work to be assured.

The novel HLA-A allele, HLA-A*02:952, first described in a Brazilian individual.

The novel HLA-A*02:952 allele, first described in a potential bone marrow donor from Brazil.

Perioperative mortality in older patients: a systematic review with a meta-regression analysis and meta-analysis of observational studies.

STUDY OBJECTIVE: Older patients have a higher probability of developing major complications during the perioperative period than other adult patients. Perioperative mortality depends on not only on a patient condition but also on the quality of perioperative care provided. We tested the hypothesis that the perioperative mortality rate among older patients has decreased over time and is related to a country's Human Development Index (HDI) status. DESIGN: A systematic review with a meta-regression and meta-analysis of observational studies that reported perioperative mortality rates in patients aged ≥60 years was performed. We searched the PubMed, EMBASE, LILACS and SciELO databases from inception to December 30, 2019. SETTING: Mortality rates up to the seventh postoperative day were evaluated. MEASUREMENTS: We evaluated the quality of the included studies. Perioperative mortality rates were analysed by time, country HDI status and baseline American Society of Anesthesiologists (ASA) physical status using meta-regression. Perioperative mortality and ASA status were analysed in low- and high-HDI countries during two time periods using proportion meta-analysis. MAIN RESULTS: We included 25 studies, which reported 4,412,100 anaesthesia procedures and 3568 perioperative deaths from 12 countries. Perioperative mortality rates in high-HDI countries decreased over time (P = 0.042). When comparing pre-1990 to 1990-2019, in high-HDI countries, the perioperative mortality rates per 10,000 anaesthesia procedures decreased 7.8-fold from 100.85 (95% CI 43.36 to 181.72) in pre-1990 to 12.98 (95% CI 6.47 to 21.70) in 1990-2019 (P < 0.0001). There were no studies from low-HDI countries pre-1990. In the period from 1990 to 2019, perioperative mortality rates did not differ between low- and high-HDI countries (P = 0.395) but the limited number of patients in low-HDI countries impaired the result. Perioperative mortality rates increased with increasing ASA status (P < 0.0001). There were more ASA III-V patients in high-HDI countries than in low-HDI countries (P < 0.0001), and the perioperative mortality rate increased 24-fold in ASA III-V patients compared with ASA I-II patients (P < 0.0001). CONCLUSION: The perioperative mortality rates in older patients have declined over the past 60 years in high-DHI countries, highlighting that perioperative safety in this population is increasing in these countries. Since data prior to 1990 were lacking in low-HDI countries, the evolution of their mortality rates could not be analysed. The perioperative mortality rate was similar in low- and high-HDI countries in the post-1990 period, but the low number of patients in the low-HDI countries does not allow a definitive conclusion.

COVID-19 in long-term care facilities in Brazil: serological survey in a post-outbreak setting

This cross-sectional seroepidemiological survey presents the seroprevalence of SARS-CoV-2 in a population living in 15 Long-Term Care Facilities (LTCFs), after two intra-institutional outbreaks of COVID-19 in the city of Botucatu, Sao Paulo State, Brazil. Residents were invited to participate in the serological survey performed in June and July 2020. Sociodemographic and clinical characterization of the participants as well as the LTCF profile were recorded. Blood samples were collected, processed and serum samples were tested using the rapid One Step COVID-19 immunochromatography test to detect IgM and IgG anti-SARS-CoV-2. Among 209 residents, the median of age was 81 years old, 135 (64.6%) were female and 171 (81.8%) self-referred as being white. An overall seroprevalence of 11.5% (95% CI: 7.5% – 16.6%) was found. The highest seroprevalences of 100% and 76.9% were observed in LTCFs that had experienced COVID-19 outbreaks. Most residents with positive immunochromatography tests (70.8%) referred previous contact with a confirmed COVID-19 case. Although there was a relatively low seroprevalence of COVID-19 in the total number of elderly people, this population is highly vulnerable and LTCFs are environments at higher risk for COVID-19 dissemination. A well-established test for COVID-19 policies, the adequate characterization of the level of interaction between residents and the healthcare provider team and the level of complexity of care are crucial to monitor and control the transmission of SARS-CoV-2 in these institutions.

Identifying and managing frailty in Brazil: a scoping review protocol.

OBJECTIVE: The objective of this review is to scope the evidence on how researchers, health, and social care professionals in Brazil currently identify and manage frailty in older adults. INTRODUCTION: The rapidly aging population and associated increased healthcare usage by older people with frailty are challenging the sustainability of healthcare for older people in Brazil. Understanding how frailty is identified, measured, categorized, and managed in Brazil is an important part of building a response to the challenge. INCLUSION CRITERIA: This scoping review will consider studies that included older Brazilian adults (≥60 years old) recruited from different settings (community, primary care, health care centers, hospital, and long-term care institutions). Studies will be included if they involved any kind of frailty assessment (tools, scales, and measures) and/or interventions. This review will consider all study designs, regardless of their rigor. National policies for older people will be also be considered for analysis. METHODS: Indexed and gray literature in English or Portuguese from 2001 to the present will be considered. The searches will be conducted using bibliographic databases, university repositories, and the Brazilian Government official database. The studies will be independently screened according to the inclusion criteria by two reviewers based on their title, abstract, and full text. In case of disagreement, a third reviewer will be consulted. A customized data extraction form will be used to extract data from the included studies. The results will be presented in tabular form, accompanied by a narrative summary related to the objective of the present scoping review.

OCCURRENCE OF INFECTION AND MORTALITY BY COVID-19 IN CARE HOMES FOR OLDER PEOPLE IN BRAZIL / OCORRÊNCIA DE INFECÇÃO E MORTALIDADE POR COVID-19 EM RESIDENCIAIS PARA IDOSOS NO BRASIL

Introduction: Mortality rates due to COVID-19 in older people living in long-term care homes reach 80% in some countries. In Brazil, little is known about the incidence and mortality in this population. Objective: To describe the occurrence of COVID-19 infection and mortality in care homes for the older people in Brazil. Methods: Cross-sectional and descriptive study using primary and secondary sources and non-probabilistic sampling. Between April and June 2020, through an electronic questionnaire, care homes administrators from all over Brazil were invited to report the occurrence of infection and mortality of residents by COVID-19. In addition, an active search for data was carried out with the services of the State Public Prosecutor Offices, State Health Departments and the Unified Social Assistance System. The data were analyzed using descriptive statistics. Results: Information from 1,802 care homes from 11 states was analyzed, where 42,216 older people lived. The incidence rate of COVID-19 was 6.14%, and 458 deaths were recorded in the period, with a case-fatality rate of 17.65%. Conclusion: The incidence and fatality observed in this study were lower than the rates observed in other countries. However, given the limitations regarding the collection of information and other barriers to the study, new structured data sources are essential for understanding the spread of the virus in care homes in the country.

Introdução: As taxas de mortalidade pela COVID-19 em idosos que vivem em Residenciais de Cuidado de Longa Duração (RCLD) chegam a 80% em alguns países. No Brasil, pouco se conhece sobre a incidência e mortalidade nesta população. Objetivo: Descrever a ocorrência da infecção e mortalidade por COVID-19 em RCLD para idosos no Brasil. Metodologia: Estudo transversal e descritivo com uso de fontes primárias e secundárias e amostragem não probabilística. Entre abril e junho de 2020, por meio de um questionário eletrônico, administradores de RCLD de todo o Brasil foram convidados a informar a ocorrência de infecção e mortalidade de residentes por COVID-19. Além disso, foi realizada busca ativa de dados junto aos serviços do Ministério Público Estadual, Secretarias de Saúde e Sistema Único de Assistência Social. Os dados foram analisados através de estatística descritiva Resultados: Foram analisadas as informações de 1,802 RCLD de 11 estados, onde residiam 42,216 idosos. A taxa de incidência de COVID-19 foi de 6,14%. Foram registrados no período 458 óbitos, com uma taxa de letalidade de 17,65%. Conclusão: A incidência e letalidade observados neste estudo foram menores do que as taxas observadas em outros países. Entretanto, dadas as limitações quanto a coleta de informações e outras barreiras para o estudo, novas fontes estruturadas de dados são fundamentais para o conhecimento da propagação do vírus nos RCLD no país.

FACING THE PANDEMIC OF COVID-19 BY THE MANAGERS OF CARE HOMES FOR OLDER PEOPLE IN LATIN AMERICA / EVALUACIÓN DE LA PANDEMIA DE COVID-19 POR LOS GERENTES DE ESTABLECIMIENTOS DE LARGA ESTADIA PARA PERSONAS MAYORES EN AMÉRICA LATINA / ENFRENTAMENTO A PANDEMIA DE COVID-19 POR PARTE DOS GESTORES DE INSTITUIÇÕES DE LONGA PERMANÊNCIA PARA IDOSOS NA AMÉRICA LATINA

Introduction: Few information is available on coping and mitigating COVID-19 in long-term care services for older people (ILPIs) in Latin America (LA). Objectives: To describe how ILPI managers in LA planned and adapted their coping routines to the COVID-19 pandemic, and whether they were able to comply with the recommendations of the World Health Organization (WHO). Methodology: Cross-sectional study, based on the application of an online survey aimed at LTCF managers in LA. A 46-question questionnaire (adopting WHO principles) was sent to participants. Descriptive statistics was used to summarize the data. Results: 23 managers answered the survey (excluding Brazilian respondents), totaling 874 older person (5 -270); a questionnaire was excluded due to lack of answers. Fourteen ILPIs (63.60%) were private for profit. The rate of adherence to WHO recommendations was over 70% for most issues. A little more than half of the institutions developed a strategic coping plan, or identified strategies to deal with deaths from suspected cases. Difficulty in acquiring personal protective equipment was reported by 59.10% of the investigated LTCIs. The testing capacity for SARS-Cov-2 has been reduced (36.36% had no test). Conclusions: The rate of adherence to the recommendations proposed by WHO for coping with COVID-19 was over 70% for most investigated LTCIs. Strategic coping plans were developed in just over half of the institutions. The availability of PPE and the testing capacity for SARS-Cov-2 proved to be quite unsatisfactory.

Introdução: Pouco se sabe sobre o enfrentamento e mitigação à COVID-19 em serviços de longa permanência para idosos (ILPIs) na América Latina (AL). Objetivos: Descrever como os gestores de ILPIs na AL planejaram e adequaram suas rotinas de enfrentamento à pandemia de COVID-19, e se foram capazes de cumprir com as recomendações da Organização Mundial da Saúde(OMS). Metodologia: Estudo transversal, baseado na aplicação de uma pesquisa online dirigida aos gestores de ILPIs na AL. Um questionário de 46 questões (adotando os princípios da OMS) foi enviado aos participantes. Estatística descritiva foi usada para resumir os dados. Resultados: 23 gestores responderam a pesquisa (excluídos os respondentes brasileiros), totalizando 874 idosos (5 ­270); um questionário foi excluído por falta de respostas. Quatorze ILPIs (63,60%) eram privadas com fins lucrativos. A taxa de adesão às recomendações da OMS foi superior a 70% para a maioria das questões. Pouco mais da metade das instituições elaborou um plano estratégico de enfrentamento, ou identificou estratégias para lidar com óbitos de casos suspeitos. Dificuldade para a aquisição de equipamentos de proteção individual foram relatados por 59,10% das ILPIs investigadas. A capacidade de testagem para o SARS-Cov-2 foi reduzida (36,36% não dispunham de nenhum teste). Conclusões: A taxa de adesão às recomendações propostas pela OMS para o enfrentamento da COVID-19 foi superior a 70% para a maioria das ILPIs investigadas. Planos estratégicos de enfrentamento foram elaborados em pouco mais da metade das instituições. A disponibilidade de EPIs e a capacidade de testagem para o SARS-Cov-2 mostrou-se bastante insatisfatória.

Anticoagulant treatment for subsegmental pulmonary embolism.

BACKGROUND: Acute pulmonary embolism (PE) is a common cause of death, accounting for 50,000 to 200,000 deaths annually. It is the third most common cause of mortality among the cardiovascular diseases, after coronary artery disease and stroke. The advent of multi-detector computed tomographic pulmonary angiography (CTPA) has allowed better assessment of PE regarding visualisation of the peripheral pulmonary arteries, increasing its rate of diagnosis. More cases of peripheral PEs, such as isolated subsegmental PE (SSPE) and incidental PE, have thereby been identified. These two conditions are usually found in patients with few or none of the classic PE symptoms such as haemoptysis or pleuritic pain, acute dyspnoea or circulatory collapse. However, in patients with reduced cardiopulmonary reserve, classic PE symptoms can be found with isolated SSPEs. Incidental SSPE is found casually in asymptomatic patients, usually by diagnostic imaging performed for other reasons (for example routine CT for cancer staging in oncology patients). Traditionally, all PEs are anticoagulated in a similar manner independent of their location, or number and size of the thrombi. It has been suggested that many patients with SSPE may be treated without benefit, increasing adverse events by a possible unnecessary use of anticoagulants. Patients with isolated SSPE, or incidental PE, may have a more benign clinical presentation compared to those with proximal PEs. However, the clinical significance in patients, and their prognosis, needs to be studied to evaluate whether anticoagulation therapy is required. This is the second update of the Cochrane systematic review published in 2014. OBJECTIVES: To assess the effectiveness and safety of anticoagulation therapy versus control in patients with isolated subsegmental pulmonary embolism (SSPE) or incidental SSPE. SEARCH METHODS: The Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register, CENTRAL, MEDLINE, Embase, CINAHL and AMED databases and World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov trials registers to 26 November 2019. We also undertook reference checking to identify additional studies. SELECTION CRITERIA: We included randomised controlled trials of anticoagulation therapy versus control in patients with SSPE or incidental SSPE. DATA COLLECTION AND ANALYSIS: Two review authors inspected all citations identified to ensure reliable assessment. If relevant studies were identified, we planned for two review authors to independently extract data and to assess the methodological quality of identified trials using the criteria recommended in the Cochrane Handbook for Systematic Reviews of Interventions. MAIN RESULTS: We did not identify any studies that met the inclusion criteria. AUTHORS' CONCLUSIONS: There is no evidence from randomised controlled trials to assess the effectiveness and safety of anticoagulation therapy versus control in patients with isolated subsegmental pulmonary embolism (SSPE) or incidental SSPE. Well-conducted research is required before informed practice decisions can be made.

Outpatient versus inpatient treatment for acute pulmonary embolism.

BACKGROUND: Pulmonary embolism (PE) is a common life-threatening cardiovascular condition, with an incidence of 23 to 69 new cases per 100,000 people each year. For selected low-risk patients with acute PE, outpatient treatment might provide several advantages over traditional inpatient treatment, such as reduction of hospitalisations, substantial cost savings, and improvements in health-related quality of life. This is an update of the review first published in 2014. OBJECTIVES: To compare the efficacy and safety of outpatient versus inpatient treatment in low-risk patients with acute PE for the outcomes of all-cause and PE-related mortality; bleeding; adverse events such as haemodynamic instability; recurrence of PE; and patients' satisfaction. SEARCH METHODS: The Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register, CENTRAL, MEDLINE, Embase, CINAHL and AMED databases, and the World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov trials registers, to 26 March 2018. We also undertook reference checking to identify additional studies. SELECTION CRITERIA: We included randomised controlled trials of outpatient versus inpatient treatment of adults (aged 18 years and over) diagnosed with low-risk acute PE. DATA COLLECTION AND ANALYSIS: Two review authors selected relevant trials, assessed methodological quality, and extracted and analysed data. We calculated effect estimates using risk ratio (RR) with 95% confidence intervals (CIs), or mean differences (MDs) with 95% CIs. We used standardised mean differences (SMDs) to combine trials that measured the same outcome but used different methods. We assessed the quality of the evidence using GRADE criteria. MAIN RESULTS: One new study was identified for this 2018 update, bringing the total number of included studies to two and the total number of participants to 451. Both trials discharged patients randomised to the outpatient group within 36 hours of initial triage and both followed participants for 90 days. One study compared the same treatment regimens in both outpatient and inpatient groups, and the other study used different treatment regimes. There was no clear difference in treatment effect for the outcomes of short-term mortality (30 days) (RR 0.33, 95% CI 0.01 to 7.98, P = 0.49; low-quality evidence), long-term mortality (90 days) (RR 0.98, 95% CI 0.06 to 15.58, P = 0.99, low-quality evidence), major bleeding at 14 days (RR 4.91, 95% CI 0.24 to 101.57, P = 0.30; low-quality evidence) and at 90 days (RR 6.88, 95% CI 0.36 to 132.14, P = 0.20; low-quality evidence), minor bleeding (RR 1.08, 95% CI 0.07 to 16.79; P = 0.96, low-quality evidence), recurrent PE within 90 days (RR 2.95, 95% CI 0.12 to 71.85, P = 0.51, low-quality evidence), and participant satisfaction (RR 0.97, 95% CI 0.90 to 1.04, P = 0.39; moderate-quality evidence). We downgraded the quality of the evidence because the CIs were wide and included treatment effects in both directions, the sample sizes and numbers of events were small, and because the effect of missing data and the absence of publication bias could not be verified. PE-related mortality, and adverse effects such as haemodynamic instability and compliance, were not assessed by the included studies. AUTHORS' CONCLUSIONS: Currently, only low-quality evidence is available from two published randomised controlled trials on outpatient versus inpatient treatment in low-risk patients with acute PE. The studies did not provide evidence of any clear difference between the interventions in overall mortality, bleeding and recurrence of PE.

Influence of Intradialytic Aerobic Training in Cerebral Blood Flow and Cognitive Function in Patients with Chronic Kidney Disease: A Pilot Randomized Controlled Trial.

BACKGROUND AND OBJECTIVES: Changes in cerebral blood flow may play an important role in cognitive impairment among hemodialysis (HD) patients. Physical activity has a promising role in delaying cognitive impairment in general population, but there are only a few studies in HD to confirm this finding. We aimed to evaluate the effects of intradialytic aerobic training on cerebral blood flow and cognitive impairment in HD. DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENTS: This is a pilot, controlled, randomized trial. Fifteen patients underwent intradialytic aerobic training 3 times a week for 4 months. The control group was comprised of another 15 patients. RESULTS: Trained patients had a statistically significant improvement of cognitive impairment and basilar maximum blood flow velocity. The proportion of arteries with increased flow velocity was statistically significant between groups. CONCLUSIONS: Intradialytic aerobic training improves cognitive impairment and cerebral blood flow of patients in HD, suggesting a possible mechanism improving cognitive impairment by physical training in HD. These data still need to be confirmed by major trials.